ONEMEDNET CORP C/WTS 07/11/2028 (TO PUR COM)

OneMedNet reports FY25 net loss decrease and revenue surge, plans to raise funds

Meiwu Tech

Amesite

InMed Pharmaceuticals

Generation Income Properties

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Co-Diagnostics

MetaVia

Phoenix Asia

BAYVIEW ACQUISITION CORPORATION COM USD0.0001 (S/R) 17/11/2028

Gen Digital - Rights

ONMD

ONMDW

LABU

SBIO

OneMedNet shares are trading higher after Form 4 filings showed that the CMO acquired over 1.1 million shares at an average price of $0.83 per share and a Director acquired over 8765,000 shares at an average price of $0.86 per share.

benzinga_article

OneMedNet

First Trust NYSE Arca Biotech Index Fd

SPDR S&P Biotech

Direxion S&P Biotech Bull 3X

Invesco Biotechnology & Genome ETF

VanEck Biotech ETF

ALPS Medical Breakthrough

iShares Biotechnology ETF

Proshares Ultra Nasdaq Biotech

Direxion S&P Biotech Bear 3X

OneMedNet Corporation (NASDAQ:ONMD) Director Thomas Kosasa purchased 595,238 shares at $0.84 each, totaling $499,999.92, on February 6th. This acquisition increased his holdings to 16,380,429 shares, valued at approximately $13.76 million. The stock rose 24.1% to $1.10 during trading. Despite this, Weiss Ratings maintains a "sell (d-)" rating on the stock, which has a market cap of $57.58 million and a PE ratio of -15.76. Institutional investors own 0.95% of the company, which specializes in clinical imaging solutions.

Market Beat

Palantir Tech

State Street

Virtu Finc

State Street® US Equity Premium Inc ETF

Insider Buying: OneMedNet (NASDAQ:ONMD) Director Acquires 595,238 Shares of Stock

Earnings Watch

ONEMEDNET CORP C/WTS 07/11/2028 (TO PUR COM) | 10-K: FY2025 Revenue: USD 1.359 M

PLTW

OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data | ONMD Stock News

StockTitan

Roundhill PLTR WeeklyPay ETF

SPDR S&P Software

Leverage Shares 2X Long PLTR Daily ETF

Leverage Shares 2x Cpd Acclrtd PLTRMnETF

iShares Expanded Tech Software Sector ETF

Direxion Daily PLTR Bull 2X Shares

GraniteShares 2x Long PLTR Daily ETF

OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data | ONMD Stock News

ONCO

OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI | ONMD Stock News

Onconetix

Health Care Select Sector SPDR

iShares US Pharma

VG Health

Ark Genomic Revolution ETF

iShares Global Healthcare

OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI | ONMD Stock News

ONWARD Medical Reports Full Year 2025 Financial and Operating Results, Highlighting Strong US Commercial Performance and Major Pipeline Milestones | ONWRY Stock News

SPDR S&P Health Equip

iShares US Medical Devices

Tenon Medical

ONWARD Medical Reports Full Year 2025 Financial and Operating Results, Highlighting Strong US Commercial Performance and Major Pipeline Milestones | ONWRY Stock News

OneMedNet and Navidence Announce Strategic Collaboration: Empowering Pharma with Precision Real-World Data Insights | ONMD Stock News

OneMedNet and Navidence Announce Strategic Collaboration: Empowering Pharma with Precision Real-World Data Insights | ONMD Stock News

OneMedNet Corporation (NASDAQ:ONMD) experienced a 45.8% increase in short interest in February, totaling 326,990 shares as of February 13th. This rise from 224,270 shares on January 29th indicates that 1.2% of the company's shares are currently short sold, with a short-interest ratio of 1.2 days based on an average daily volume of 283,072 shares. Institutional investors have also made changes to their positions in ONMD, with a majority holding 0.95% of the stock. Analysts maintain a "sell" rating on the stock, which is currently trading at $1.02.

OneMedNet Corporation (NASDAQ:ONMD) Short Interest Up 45.8% in February

ONEMEDNET CORP C/WTS 07/11/2028 (TO PUR COM)(ONMDW.US)

OneMedNet shares are trading higher after Form 4 filings showed that the CMO acquired over 1.1 million shares at an average price of $0.83 per share and a Director acquired over 8765,000 shares at an average price of $0.86 per share.

Insider Buying: OneMedNet (NASDAQ:ONMD) Director Acquires 595,238 Shares of Stock

ONEMEDNET CORP C/WTS 07/11/2028 (TO PUR COM) | 10-K: FY2025 Revenue: USD 1.359 M

OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data | ONMD Stock News

OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI | ONMD Stock News

ONWARD Medical Reports Full Year 2025 Financial and Operating Results, Highlighting Strong US Commercial Performance and Major Pipeline Milestones | ONWRY Stock News

OneMedNet and Navidence Announce Strategic Collaboration: Empowering Pharma with Precision Real-World Data Insights | ONMD Stock News

OneMedNet Corporation (NASDAQ:ONMD) Short Interest Up 45.8% in February